Pipeline

Global

Designated Asian Regions

Mainland China, Hong Kong, Macao and Taiwan

China

Overseas

Product	Rights Authorized Region***	Indication	Clinical Trial Approval	Clinical Trial for Registration	Marketing Application	Marketed	Major Marketed Regions
							CN	US	EU	JP
Methotrexate Injection		Severe recalcitrant disabling psoriasis and other autoimmune diseases					√		√
		Adult rheumatoid arthritis							√
Diazepam Nasal Spray		Intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) in patients with epilepsy six years of age and older					√	√
Tildrakizumab Solution for Injection (Biological Agent)		Moderate-to-severe plaque psoriasis					√	√	√	√
Methylthioninium Chloride Enteric-coated Sustained-release Tablets		An diagnostic agent to enhance visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy							√
Desidustat Tablets		Anemia in patients with chronic kidney disease
Cyclosporine Eye Drops 0.09%		Increasing tear secretion in patients with keratoconjunctivitis sicca (dry eye)						√
PLENITY		An aid for weight management in adults with a BMI of 25-40 kg/m2 when used in conjunction with diet and exercise						√	√
Latanoprost Eye Drops		Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension						√
Ruxolitinib cream		Topical treatment of nonsegmental vitiligo in adults and pediatric patients aged 12 years of age and older						√
		Topical short-term and non-continuous chronic treatment of mild to moderate AD in non-immunocompromised adult and pediatric patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable
Levetiracetam XR Tablet		Adjunctive therapy for the treatment of partial-onset seizures						√
BCG for Intravesical Instillation (Biological Agent)	**	Non-invasive urothelial bladder carcinoma, including curative treatment of carcinoma in situ and prophylactic treatment of recurrence							√
PoNS		Chronic balance deficit due to mild-to-moderate traumatic brain injury

**Taiwan is not included in the rights authorized region of BCG for Intravesical Instillation
*** CMS has NO development, commercialization and other related products’ rights in any unauthorized region
As at 30^th June 2023